Ujjani, C., Mato, A., Hill, B. T., Allan, J. N., Lansigan, F., Jacobs, R., . . . Shadman, M. (2020). The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy. Blood Lymphat Cancer.
Style de citation ChicagoUjjani, Chaitra, et al. "The Impact of Age On Survival in CLL Patients Receiving Ibrutinib As Initial Therapy." Blood Lymphat Cancer 2020.
Style de citation MLAUjjani, Chaitra, et al. "The Impact of Age On Survival in CLL Patients Receiving Ibrutinib As Initial Therapy." Blood Lymphat Cancer 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.